In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Physiometrix Inc.

Division of Pfizer Inc.

Latest From Physiometrix Inc.

EyeTect: Starting Over with OMT for Neuro Intensive Care

For its first three years, EyeTect, developers of an innovative technology using ocular microtremors to monitor brain function, was the very model of efficient device development. With less than $1 million raised, the company developed a working device, funded several important clinical studies, and even got FDA clearance. But when an anticipated marketing agreement with a well-established competitor fell through, the company all but shut down. Now EyeTect is starting again, with a new managment team and a new target application.
Medical Device Strategy

How Many US Salespeople Does It Take to Sell Medical Devices?

In the course of working with nearly 100 medical device and diagnostics clients over the last 12 years, consulting firm Health Advances has identified several successful strategies for determining the most appropriate sales force size to suit a specific product. In Vivo presents them here as a set of four best demonstrated practices, which are designed to help device companies more cost-effectively field the right size sales force for their particular devices.
Medical Device

Top Ten Pitfalls to New Medical Device Launches

It is not uncommon for a new medical device to fail to initially live up to projected sales expectations. Early disappointing product sales can produce a hole that a company can spend a long time trying to dig its way out of, having to battle a declining stock price, decreased investor confidence, lower company valuations, and diminished access to capital. The end result may be that both the product and the company are never able to fully recover from the early set-back. Many initial disappointing product roll-outs can be attributed to problems that commonly confront device companies. Product companies have adopted successful strategies to anticipate and overcome many of these issues, and thereby increase the chances of a new product coming strong out-of-the blocks.
Medical Device Reimbursement

More from the Device Innovators' Workbench

Interviews with medical device inventors/entrepreneurs Rodney Perkins, MD, and Mir Imran, discussing their successes, such as Collagen and PercuSurge, and the ones that didn't make it.
Medical Device Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
  • Therapeutic Areas
  • Neurology, Nervous System > Anesthesia
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Pfizer Inc.
  • Senior Management
  • John A Williams, Pres. & CEO
    Daniel W Muehl, SVP, CFO
    Timothy A Hagerty, VP, Sales & Mktg.
    Dominic P Marro, SVP, R&D & CTO
  • Contact Info
  • Physiometrix Inc.
    Phone: (978) 670-2422
    5 Billerica Park
    101 Billerica
    North Billerica, MA 01862